Related by context. All words. (Click for frequent words.) 75 primary hypercholesterolemia 69 metformin sulfonylurea 69 hypercholesterolemia 69 6R BH4 68 lipid lowering agents 68 diabetic neuropathic pain 68 AEGR 67 severe hypercholesterolemia 67 dyslipidemia 66 hyperuricemia 66 pegylated interferons 66 angiotensin receptor blocker ARB 66 visilizumab 66 eprotirome 66 hypertriglyceridemia 66 homozygous familial hypercholesterolemia 65 DPP4 inhibitor 65 xanthine oxidase inhibitor 65 insulin detemir 65 DU #b 65 diarrhea predominant irritable 65 lomitapide 65 lintuzumab SGN 65 CYCLOSET 65 HoFH 65 NYHA Class II 65 Rebif ® 64 relapsed refractory multiple myeloma 64 refractory gout 64 pramlintide 64 alvespimycin 64 orally administered inhibitor 64 ALN HPN 64 mixed hyperlipidemia 64 oral antidiabetic medication 64 sodium glucose cotransporter 64 selective modulator 64 Phenoptin 64 sorafenib Nexavar 64 acarbose 64 secondary hyperparathyroidism 64 sorafenib tablets 64 metaglidasen 63 elevated LDL cholesterol 63 relapsed multiple myeloma 63 dyslipidaemia 63 posaconazole 63 mipomersen 63 lipid disorders 63 ISIS # 63 Oral NKTR 63 chronic HCV infection 63 PEG PAL 63 PHX# 63 tolvaptan 63 ARCOXIA 63 Zerenex 63 familial amyloidotic polyneuropathy FAP 63 delta gamma agonist 63 ularitide 63 elotuzumab 63 pramlintide metreleptin 63 BYETTA ® 63 aflibercept VEGF Trap 63 prokinetic agent 63 NPH insulin 63 TNF antagonists 63 RSD# oral 63 VIAtab TM 63 JANUVIA 63 vildagliptin 63 oral antidiabetic 63 irbesartan 63 hyperphenylalaninemia HPA due 63 symptomatic BPH 63 SNRI 63 severe renal impairment 63 Cleviprex TM clevidipine 63 antidiabetic 63 Avanafil 63 candesartan cilexetil 63 Chronic Idiopathic Constipation 63 PEGINTRON TM 63 SCH # 63 phase IIb clinical 62 cell lymphoma CTCL 62 NATRECOR R 62 non valvular atrial 62 ruboxistaurin 62 INCB# [003] 62 thiazolidinedione 62 forodesine 62 lipid lowering 62 hypercholesterolaemia 62 T2DM 62 Letairis ambrisentan 62 bendamustine 62 acute coronary syndromes ACS 62 induced macular edema 62 fenofibric acid 62 selective androgen receptor modulator 62 CTAP# Capsules 62 castrate resistant prostate cancer 62 rheumatoid arthritis psoriatic arthritis 62 SARMs 62 hyperlipidemia 62 BENLYSTA ® 62 sitagliptin 62 BAY #-# 62 hoFH 62 tasocitinib 62 multicenter Phase III 62 ACTEMRA TM 62 FOLOTYN ® 62 YONDELIS 62 TELINTRA 62 sunitinib malate 62 Mipomersen 62 ATACAND 62 post herpetic neuralgia PHN 62 phase IIb trial 62 antithrombotics 62 refractory multiple myeloma 62 lesinurad 62 ceftazidime 62 elevated triglycerides 62 Ophena TM 62 olanzapine Zyprexa 62 active comparator 62 CIMZIA ™ 62 valsartan 62 ALN PCS 62 antihypertensive agents 62 BENICAR 62 rosuvastatin Crestor 62 BENICAR HCT 62 bicifadine 62 Diabetic Macular Edema 62 ISTODAX 62 atherothrombotic events 62 adecatumumab 62 PRTX 62 hypoparathyroidism 62 TBC# 62 RELOVAIR ™ 62 antihypertensive drugs 62 non alcoholic steatohepatitis 62 myopathy rhabdomyolysis 62 oral prodrug 62 hereditary deficiency 62 ONGLYZA 62 lupus nephritis 62 DDP# 62 dextromethorphan quinidine 62 gastrointestinal disorders ATI 62 HuLuc# 61 PREZISTA r 61 rhIGF-I/rhIGFBP-3 61 Dapagliflozin 61 PSN# [002] 61 inhibitor RG# 61 NATRECOR ® 61 Ostarine 61 atherogenic dyslipidemia 61 pioglitazone HCl 61 macrovascular events 61 metastatic HRPC 61 Nexavar ® 61 dyslipidemias 61 investigational oral 61 selective androgen receptor modulators 61 Tezampanel 61 OADs 61 refractory AML 61 stable angina 61 virus HCV infection 61 Vaprisol 61 IIIa inhibitor 61 metformin sulfonylureas 61 LHRH antagonists 61 interferon alfa 2b 61 myelofibrosis polycythemia vera 61 Plicera 61 thiazolidinediones TZDs 61 oral rivaroxaban 61 neuropathic pain metabolic diseases 61 esophageal candidiasis 61 HCV SPRINT 61 lipid abnormalities 61 R sorafenib tablets 61 CIMZIA TM 61 virus HCV protease inhibitor 61 ALGRX 61 CEQ# 61 transthyretin mediated amyloidosis ATTR 61 HMG CoA reductase inhibitors 61 toenail onychomycosis 61 opioid induced bowel dysfunction 61 antiarrhythmic drug 61 risperidone Risperdal 61 DCCR 61 HeFH 61 albinterferon alfa 2b 61 pulmonary arterial hypertension PAH 61 acute migraine 61 dose regimens 61 systemic lupus erythematosus SLE 61 phase IIa clinical 61 alpha interferons 61 albiglutide 61 riociguat 61 Clonicel 61 Apidra ® 61 SILENOR 61 tanespimycin 61 insulin glargine 61 interferon gamma 1b 61 Ramipril 61 azilsartan medoxomil 61 cognitive impairment associated 61 eosinophilic asthma 61 AVONEX ® 61 PDX pralatrexate 61 fibrate 61 PEGylated anti 61 ADL# novel 61 oral antidiabetic agents 61 erlotinib Tarceva ® 61 statin monotherapy 61 ALN TTR 61 Welchol 61 Phase 2b study 61 Lantus ® 61 carcinoid syndrome 61 urate lowering 61 sorafenib Nexavar ® 61 Glimepiride 61 allopurinol 61 overt nephropathy 61 angiotensin II receptor blocker 61 essential thrombocythemia 61 Pruvel 61 Bicifadine 61 cutaneous T 61 ACE inhibitor ramipril 61 purpura ITP 61 biphasic insulin aspart 61 AAG geldanamycin analog 61 NVA# 61 metastatic hormone refractory 61 Zenvia ™ 61 severe renal insufficiency 61 subcutaneously administered 61 schizophrenia CIAS 61 Traficet EN 61 dihydrochloride Tablets 61 LDL lowering 61 teriflunomide 61 Eliquis 61 tezampanel 61 endothelin receptor antagonists 60 APTIVUS r 60 serotonin norepinephrine reuptake inhibitor 60 PS# [001] 60 systemic lupus erythematosus lupus 60 relapsed MM 60 JAK inhibitor 60 immunomodulatory therapy 60 Tekamlo 60 CYT# potent vascular disrupting 60 Actimmune ® 60 pitavastatin 60 muraglitazar 60 alvimopan 60 chemotherapy induced neutropenia 60 HZT 60 INTEGRILIN 60 Amrubicin 60 metformin HCl 60 ACTOplus met 60 controlled multicenter 60 AMR# 60 docetaxel Taxotere ® 60 serum phosphate 60 diabetic nephropathy 60 squalamine 60 lipid lowering therapies 60 Ozarelix 60 Pimavanserin 60 somatostatin analogue 60 angiotensin receptor blocker 60 cholesterol LDL C 60 eculizumab 60 blinded randomized placebo controlled 60 oral anticoagulant 60 Cetrorelix 60 XP# XP# 60 Cloretazine 60 glitazones 60 placebo controlled Phase 60 aspirin clopidogrel 60 PEG INTRON 60 Contrave# 60 #mg/dL [001] 60 sulphonylurea 60 dacarbazine 60 torezolid phosphate 60 PAOD 60 salmeterol fluticasone 60 MAP# 60 histone deacetylase HDAC inhibitor 60 MEND CABG 60 dasatinib Sprycel ® 60 Saxagliptin 60 receptor tyrosine kinase inhibitor 60 TREDAPTIVE 60 ARIKACE ™ 60 ezetimibe Zetia 60 cutaneous T cell 60 myelofibrosis 60 Omacetaxine mepesuccinate 60 reslizumab 60 either acutely decompensated 60 catheter occlusion 60 regorafenib 60 VAPRISOL 60 Fibrillex TM 60 adenosine injection 60 double blinded placebo 60 glargine 60 placebo controlled clinical trials 60 mGluR5 negative 60 calcineurin inhibitors 60 Aflibercept 60 hematologic malignancies 60 ULORIC 60 INC# 60 INVANZ 60 osteoarthritis rheumatoid arthritis 60 Diovan Exforge Tekturna Zelnorm 60 cancer cachexia 60 CRx 60 NUVIGIL 60 lipid parameters 60 dyskinesia PD LID 60 Eltrombopag 60 Clolar ® 60 Anturol TM 60 refractory NSCLC 60 evaluating tivozanib 60 sodium thiosulfate STS 60 aHUS 60 CRVO 60 FOSRENOL R 60 thymalfasin 60 Fibrates 60 octreotide 60 colesevelam HCl 60 Gabapentin GR 60 thiazide diuretic 60 Sudhir Agrawal D.Phil 60 MKC# 60 Phase 1b trial 60 BEMA Buprenorphine 60 febuxostat 60 Navelbine ® 60 COU AA 60 Entereg R 60 MAGE A3 ASCI 60 dimebon 60 certolizumab 60 synthetic retinoid 60 elevated triglyceride levels 60 INCB# [001] 60 mycophenolate mofetil 60 investigational therapies 60 KRN# 60 rALLy clinical trial 60 Insulin detemir 60 HBeAg negative 60 RhuDex ® 60 oral ridaforolimus 60 edoxaban 60 LATUDA 60 GFT# 60 hematological malignancies 60 Neulasta R 60 heterozygous FH 60 benazepril 60 Lu AA# 60 ZYBRESTAT fosbretabulin 60 conventional antipsychotics 60 PEGylated interferon beta 1a 60 OMNARIS HFA 60 dual PPAR peroxisome 60 Pegasys ® 60 Phase Ib 60 Phase 2a trial 60 serum urate 60 aripiprazole 60 ALVESCO HFA 60 AGILECT R 60 #mg doses [002] 60 Pafuramidine 60 generation purine nucleoside 60 oral antidiabetes drugs 60 Lixivaptan 60 SILENOR TM 60 constipation OIC 60 pegylated interferon alpha 60 registrational 60 HCV protease inhibitor 60 sapropterin dihydrochloride Tablets 59 mGluR5 NAM 59 angiotensin converting enzyme inhibitor 59 Ambrisentan 59 triglyceride TG 59 metastatic castration resistant 59 chlorambucil 59 IMiDs 59 fluvastatin 59 Silodosin 59 tenofovir emtricitabine 59 lumiliximab 59 MKC# MKC# PP 59 Uricase PEG 59 hypercalcemia 59 EDEMA3 59 lupus renal disease 59 ABILIFY ® 59 ritonavir boosted 59 thetreatment 59 pomalidomide 59 Triolex 59 fostamatinib 59 LUNESTA ® 59 MGd 59 refractory chronic lymphocytic 59 odanacatib 59 μg dose 59 systemic lupus erythematosus 59 methylnaltrexone bromide 59 antihypertensives 59 glycated hemoglobin levels 59 pan HDAC inhibitor 59 FAME Study 59 rNAPc2 59 pharmacologically active isomer 59 constipation IBS C 59 Panzem R 59 Epanova 59 exenatide 59 brivaracetam 59 dirucotide MBP# 59 acute coronary syndromes 59 PRISTIQ 59 metformin hydrochloride 59 darusentan 59 FOLFOX6 chemotherapy regimen 59 nalbuphine ER 59 Empatic 59 Phase IIIb clinical 59 Starlix 59 ALN TTR# 59 retinal vein occlusion induced 59 candidate XP# 59 HuMax CD4 59 venlafaxine Effexor 59 Interferon alpha 59 ZOLINZA 59 IL# PE#QQR 59 tocilizumab 59 serum triglyceride levels 59 leukotriene receptor antagonists 59 Monopril 59 acyclovir Lauriad R 59 Icatibant 59 thiazolidinedione TZD 59 TYGACIL 59 monotherapy 59 ponatinib 59 retinal vein occlusion 59 systemic juvenile idiopathic 59 XL# XL# 59 reduce serum phosphate 59 mg TID 59 fluoxetine paroxetine 59 EOquin 59 phase IIb 59 Tolvaptan 59 Archexin 59 REMINYL ® 59 antidiabetic drugs 59 AGHD 59 Muraglitazar 59 Lubiprostone 59 2 methoxyestradiol 59 Primary IGFD 59 docetaxel Taxotere R 59 phase III isavuconazole 59 MERREM 59 evaluating picoplatin 59 teduglutide 59 macroalbuminuria 59 insulin sensitizers 59 proliferator activated receptor 59 QVA# 59 pramlintide metreleptin combination 59 null responder HCV 59 davalintide 59 MKC# MT 59 Neulasta ® 59 Perforomist TM Inhalation Solution 59 CTA# Injection 59 exocrine pancreatic insufficiency 59 insulin sensitizer 59 AIM HIGH 59 atorvastatin Lipitor 59 ABILIFY 59 oral deforolimus 59 APEX PD 59 lispro 59 fasting triglyceride levels 59 MTP inhibitor 59 dexamethasone Decadron 59 antihypertensive medications 59 myeloproliferative diseases 59 tapentadol ER 59 MoxDuo IR 59 lasofoxifene 59 patients undergoing percutaneous 59 VIAject 59 systemic fungal infections 59 TG# [003] 59 oxypurinol 59 Genz # 59 AEG# 59 Sycrest 59 HQK 59 GW# [003] 59 MACUGEN 59 developing Bicifadine serotonin 59 octreotide implant 59 Sulonex TM 59 arterial thrombosis 59 lanreotide 59 otelixizumab 59 evaluating mipomersen 59 long acting muscarinic 59 canagliflozin 59 dose cohorts 59 INVEGA ® 59 E2F Decoy 59 dacetuzumab 59 betrixaban 59 unresectable HCC 59 stable angina pectoris 59 Laquinimod 59 cardiovascular morbidity 59 QNEXA 59 AGILECT ® 59 Phase 2b clinical trials 59 hyperplasia BPH 59 novel VDA molecule 59 lanthanum carbonate 59 Tarceva TM 59 linagliptin 59 olmesartan 59 LEUKINE 59 Serdaxin 59 RLY# 59 dosage regimens 59 heavily pretreated 59 chlorthalidone 59 peripherally acting 59 Sitagliptin 59 XL# anticancer compounds 59 plus COPEGUS 59 placebo controlled clinical 59 eltrombopag 59 agonist LABA 59 chronic angina 59 mTOR inhibitor 59 Milnacipran 59 hyperphosphatemia 59 XL# XL# XL# 59 plus DOXIL 59 glimepiride 59 ZYVOX 59 Omacetaxine 59 pravastatin Pravachol 59 Increlex R 59 hepatic impairment 59 daunorubicin 59 H2 receptor antagonists 59 panitumumab Vectibix 59 Dabigatran etexilate 59 naïve HCV 59 thalidomide Thalomid 59 treat hyperphosphatemia 59 cangrelor 59 anti amnesic 59 PDE4 inhibitor 59 SRT# [003] 59 chronic plaque psoriasis 59 terlipressin 59 miconazole Lauriad ® 59 TORISEL 59 ACEIs 59 diabetes dyslipidemia 59 HGS# 59 FOSRENOL ® 59 RNAi therapeutic targeting PCSK9 59 cytopenias 59 efalizumab 59 sitaxsentan 59 autoantibody positive 59 Solazed TM 59 Phase 2a clinical 59 Asentar 59 Amigal 59 Naproxcinod 59 dirucotide 59 mg BID dose 59 Inhalation Aerosol 59 TNF Tumor Necrosis Factor 59 nucleoside analog 59 INSPIRE Trial Phase III 59 liposomal formulation 59 Valsartan 59 GSK# [001] 59 GATTEX ® 59 aldosterone antagonist 59 blood phenylalanine Phe 59 rheumatoid arthritis Crohn disease 58 Proquin XR 58 Microplasmin 58 TEAEs 58 candidemia 58 Ventavis 58 sulodexide 58 unique alkylating agent 58 ADHF 58 sargramostim 58 Zorbtive TM 58 superficial bladder cancer 58 axitinib 58 CANCIDAS 58 ribavirin therapy 58 deforolimus 58 Phase Ib study 58 ENMD # 58 investigational compound 58 Phase 2b trial 58 pancreatic insufficiency 58 evaluating REVLIMID 58 Nasulin 58 INKP 58 R Saizen R 58 refractory PTCL 58 EQUIP OB 58 atrasentan 58 diabetic macular edema 58 saxagliptin 58 alkylating agent 58 pegfilgrastim 58 Phase Ib clinical 58 PROVENGE sipuleucel T 58 fluticasone propionate 58 Personalized Immunotherapy 58 peritumoral brain edema 58 metastatic GIST 58 Linagliptin 58 PEGINTRON 58 relapsing remitting MS RRMS 58 rHuPH# 58 CIMZIA TM certolizumab pegol 58 EDARBI 58 norepinephrine reuptake inhibitor 58 Oracea TM 58 aripiprazole Abilify 58 non constipating irritable 58 delta isoform 58 oral picoplatin 58 AVAPRO 58 Targretin capsules 58 AzaSite Plus 58 dasatinib Sprycel 58 Aclidinium 58 cardio renal 58 hour bronchodilation 58 celgosivir 58 myelofibrosis MF 58 compound INCB# 58 painful diabetic neuropathy 58 5 HT3 antagonist 58 PNP inhibitor 58 diabetic peripheral neuropathic pain 58 QNEXA ® 58 targeted radiotherapeutic 58 Methylnaltrexone 58 Elagolix 58 lymphoma CTCL 58 LymphoStat B 58 ARICEPT 58 refractory metastatic colorectal cancer 58 trastuzumab Herceptin R 58 urocortin 2 58 milrinone 58 ELACYT 58 AFRESA 58 ORENCIA R 58 SIMCOR 58 refractory CLL 58 investigational compounds 58 AZOR 58 EVIZON 58 psoriasis rheumatoid arthritis 58 acute decompensated heart 58 ARIXTRA 58 IAP inhibitors 58 Aryplase 58 Nuvion 58 Inhalation Solution 58 ferric citrate 58 * olmesartan medoxomil 58 Evoltra ® 58 oral diclofenac 58 Androxal TM 58 JANUMET 58 ocular hypertension 58 elevated uric acid 58 essential thrombocythemia ET 58 mRCC 58 GEM OS2 58 stavudine d4T 58 pertuzumab 58 MPS IVA 58 antiplatelet agent 58 Levetiracetam 58 atypical antipsychotic medication 58 chronic lymphocytic leukemia CLL 58 RLAI 58 cannabinor 58 placebo controlled Phase III 58 VISICOL R 58 induce orthostatic hypotension 58 Benlysta belimumab 58 familial hypercholesterolemia 58 Tyrima 58 IXEMPRA 58 clinical trials dacetuzumab SGN 58 LDL cholesterol lowering 58 phenylalanine ammonia lyase 58 functional dyspepsia 58 Seliciclib 58 pain palliation 58 non splenectomized 58 Telmisartan 58 REMICADE ® 58 Viramidine 58 oral antidiabetic drugs 58 leukemia AML 58 pouchitis 58 Keppra R 58 nephropathic cystinosis cystinosis 58 weekly subcutaneous injections 58 CrCl 58 Paxil paroxetine 58 safinamide 58 XL# XL# XL# XL# 58 renal anemia 58 beta 1a 58 dopaminergic therapy 58 fluticasone salmeterol 58 Zavesca R 58 OvaRex ® MAb 58 myeloproliferative disorders 58 Targretin 58 Mg Uk 58 lixisenatide 58 PSN# [001] 58 comparator arm 58 plus prednisone 58 ADVANCE PD 58 Pegasys peginterferon alfa 2a 58 Dalbavancin 58 Mg Usa 58 chronic HBV infection 58 Intravitreal injections 58 CORT # 58 bardoxolone 58 atypical antipsychotic 58 PEG Interferon lambda 58 Romidepsin 58 subcutaneous formulation 58 Virulizin ® 58 Trandolapril 58 fibromyalgia syndrome 58 Teriflunomide 58 Triapine 58 LymphoStat B belimumab 58 triglyceride lowering 58 TRIOLEX HE# APOPTONE HE# 58 anti arrhythmic 58 anti TNF alpha 58 IBS C 58 PegIntron 58 investigational monoclonal antibody 58 multi kinase inhibitor 58 4mg/kg 58 primary generalized tonic 58 advanced hepatocellular carcinoma 58 APTIVUS 58 MSI #F 58 opioid receptor antagonist 58 pseudobulbar affect PBA 58 Tekturna HCT 58 basal insulin 58 oxaliplatin Eloxatin 58 bezafibrate 58 intravenous methylnaltrexone 58 cisplatin gemcitabine 58 sulfonylurea glimepiride 58 Ceflatonin R 58 JAK inhibitors 58 Locteron ® 58 SEROQUEL XR 58 HCl Tablets 58 serum phosphorous 58 Daclizumab 58 cSSSI 58 DAPT 58 acute PAO 58 acting muscarinic antagonist 58 R#/MEM # 58 Ticagrelor 58 sulfonylurea 58 #mg/day [001] 58 refractory Hodgkin lymphoma 58 BRIM2 58 Phase Ib clinical trials 58 oxymorphone ER 58 darapladib 58 iobenguane 58 Navelbine 58 ANCHOR trial 58 adalimumab Humira 58 Fludara 58 NMDA antagonist 58 idraparinux 58 anticancer compound 58 potent CYP#A# inhibitors 58 Aliskiren 58 pulmonary exacerbations 58 amphotericin B 58 Golimumab 58 Blinatumomab 58 galiximab 58 GSK# [002] 58 RE LY ® 58 LY# [003] 58 Xcytrin R 58 Serdolect ® 58 BARACLUDE ® 58 ACTOS 58 prescribed proton pump 58 bosentan 58 ADP receptor antagonist 58 aldosterone antagonists 58 ORENCIA ® 58 Solzira TM 58 non metastatic osteosarcoma 58 Syncria R 58 desvenlafaxine succinate 58 Octreolin 58 arsenic trioxide injection 58 BCR ABL inhibitor 58 MK #B 58 bevacizumab Avastin ® 58 thrombolytic agent 58 AzaSite Xtra 58 metformin sulphonylurea 58 Pivotal Phase III 58 neovascular age 58 Cloretazine R VNP#M 58 GALNS 58 CCX# 58 MDV# 58 romiplostim 58 Dasatinib 58 PRT# 58 Epoetin alfa 58 VELCADE melphalan 58 Zocor simvastatin 58 interferon alfa 58 forodesine HCl 58 lexidronam injection 58 fluvastatin Lescol 58 Phase IIa trial 58 INCB# [002] 58 ascending dose 58 dosing regimens 58 CaPre TM 58 Pegloticase 58 hepatitis C HCV 58 peginterferon alfa 2b 58 CA4P 58 post herpetic neuralgia 58 symptomatic neurogenic orthostatic hypotension 58 GRALISE 58 Soriatane 58 PF # [001] 58 Copegus ® 58 bazedoxifene 58 onset diabetes mellitus 58 non constipation irritable 58 midstage clinical 58 kidney urologic 58 neovascular diseases 58 invasive candidiasis 58 rFVIIa 58 serum phosphorus 58 KAPIDEX 58 relapsing remitting multiple sclerosis 58 ABILIFY R 58 long acting bronchodilator 58 mapatumumab 58 VEGF inhibitors 58 generalized edema 58 Darusentan 58 ofatumumab 58 Dementia Related Psychosis 58 Viprinex TM 58 somatostatin analog 58 LibiGel ® 58 mcg BID 58 subcutaneous insulin 58 chronic ITP 58 tecarfarin 58 chronic HCV 57 interferon alfa 2a 57 sertraline Zoloft 57 serum triglycerides 57 SHPT 57 initiate Phase 1b 57 COLAZAL R 57 Metformin GR 57 rosuvastatin #mg 57 Azedra 57 DIFICID ™ 57 PEGylated Fab fragment 57 renin inhibitors 57 PD LID 57 neurogenic orthostatic hypotension 57 valopicitabine 57 PRX # 57 evaluating Xcytrin 57 briakinumab 57 NOXAFIL 57 SUTENT 57 FROVA 57 apremilast 57 metformin monotherapy 57 Celebrex celecoxib 57 Alzhemed TM 57 Cycloset 57 dapagliflozin plus 57 potassium sparing diuretics 57 metastatic colorectal carcinoma 57 angiotensin converting enzyme inhibitors 57 systemic corticosteroid 57 imatinib resistant 57 ospemifene 57 eritoran 57 OHR/AVR# 57 DAVANAT 57 Copegus ribavirin 57 HBeAg positive 57 Phase IIb trials 57 Allovectin 7 R 57 leukotriene receptor antagonist 57 vandetanib 57 romidepsin 57 TRILIPIX 57 tarenflurbil 57 dosing frequency 57 Noxafil 57 pediatric Crohn disease 57 TYZEKA 57 hypogonadal men 57 hyaluronidase enzyme 57 FASLODEX 57 antihypertensive therapy 57 cIAI 57 Liprotamase 57 postoperative ileus POI 57 hematologic cancers 57 topical gel formulation